KR970073592A - Blemish treatment - Google Patents

Blemish treatment Download PDF

Info

Publication number
KR970073592A
KR970073592A KR1019970018124A KR19970018124A KR970073592A KR 970073592 A KR970073592 A KR 970073592A KR 1019970018124 A KR1019970018124 A KR 1019970018124A KR 19970018124 A KR19970018124 A KR 19970018124A KR 970073592 A KR970073592 A KR 970073592A
Authority
KR
South Korea
Prior art keywords
blemish
therapeutic composition
lincosamide
composition according
dexamethasone
Prior art date
Application number
KR1019970018124A
Other languages
Korean (ko)
Other versions
KR100200240B1 (en
Inventor
김대곤
유경란
김은실
김홍용
Original Assignee
김대곤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 김대곤 filed Critical 김대곤
Publication of KR970073592A publication Critical patent/KR970073592A/en
Application granted granted Critical
Publication of KR100200240B1 publication Critical patent/KR100200240B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

본 발명은 기미 치료제에 관한 것으로, 구체적으로는 코르티코스테로이드(corticosteroid)와 린코사마이드(lincosamides)를 함유하는 기미 치료제에 관한 것이다. 본 발명의 코르티코스테로이드는 코티솔, 코르티손, 코르티코스테론, 디옥시코르티코스테론, 알도스테론, 프레드니솔론, 트리암시놀론, 파라메타손, 베타메타손, 덱사메타손 중에서 선택될 수 있고 바람직하게는 베타메타손 및 덱사메타손이며 그 함량은 0.01-10%으로 바람직하게는 0.04∼0.1%이다. 또한 본 발명의 린코사마이드는 염산 린코사마이드 및 클린다마이신 중에서 선택될 수 있고 그 함량은 0.1-50%으로 바람직하게는 1∼5%이다.The present invention relates to a blemish treatment, and more particularly, to a blemish treatment containing corticosteroids and lincosamides. Corticosteroids of the present invention may be selected from cortisol, cortisone, corticosterone, dioxycorticosterone, aldosterone, prednisolone, triamcinolone, paramethasone, betamethasone, dexamethasone, preferably betamethasone and dexamethasone, the content of which is 0.01-10 In%, Preferably it is 0.04 to 0.1%. In addition, the lincosamide of the present invention may be selected from lincosamide hydrochloride and clindamycin, and the content thereof is 0.1-50%, preferably 1-5%.

또한, 본 발명의 기미치료제는 수성 연고 베이스를 추가로 함유하는 피부크림제와 그외, 로션, 용액, 현탁액, 연고, 에로솔, 스프레이, 포말제, 이고제, 젤 및 패티제제 형태로 사용할 수 있다.In addition, the blemish treatment of the present invention can be used in the form of a skin cream further containing an aqueous ointment base and in the form of lotions, solutions, suspensions, ointments, aerosols, sprays, foams, ointments, gels and patties. .

Description

기미 치료제Blemish treatment

본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음As this is a public information case, the full text was not included.

Claims (7)

코르티코스테로이드와 린코사마이드를 함유하는 기미 치료제 조성물.A blemish therapeutic composition containing corticosteroids and lincosamide. 제1항에 있어서, 코르티코스테로이드가 코티솔, 코르티손, 코르티코스테론, 디옥시코르티코스테론, 알도스테론, 프레드니솔론, 트리암시놀른, 파라메타손, 베타메타손, 덱사메타손 중에서 선택되는 것을 특징으로 하는 기미 치료제 조성물.The blemish therapeutic composition according to claim 1, wherein the corticosteroid is selected from cortisol, cortisone, corticosterone, deoxycorticosterone, aldosterone, prednisolone, triamcinolone, paramethasone, betamethasone, dexamethasone. 제1항 또는 제2항에 있어서, 코르티코스테로이드가 베타메타손 및 덱사메타손 중에서 선택되는 것을 특징으로 하는 기미 치료제 조성물.The blemish therapeutic composition according to claim 1 or 2, wherein the corticosteroid is selected from betamethasone and dexamethasone. 제1항에 있어서, 린코사마이드가 염산 린코마이신 및 클린다마이신 중에서 선택되는 것을 특징으로 하는 기미 치료제 조성물.The blemish treatment composition according to claim 1, wherein the lincosamide is selected from hydrochloric acid lincomycin and clindamycin. 제1항에 있어서, 코르티코스테로이드 함량이 0.01-10%이고, 린코사마이드 함량이 0.1-50%인 것을 특징으로 하는 기미 치료제 조성물.The blemish therapeutic composition according to claim 1, wherein the corticosteroid content is 0.01-10% and the lincosamide content is 0.1-50%. 제1항에 있어서, 제제형태가 피부크림제로 수성 연고 베이스를 추가로 함유하는 것을 특징으로 하는 기미 치료제 조성물.The anti-fog therapeutic composition according to claim 1, wherein the formulation further comprises an aqueous ointment base as a skin cream. 제1항에 있어서, 제제형태가 로션(lotion), 용약(solution), 현탁액(suspension), 연고(ointment), 에로솔(aerosol, sparay), 포말제(foam), 이고제(paste), 젤(gel) 및 패치(patch) 인 것을 특징으로 하는 기미치료제 조성물.The formulation of claim 1 wherein the formulation is a lotion, solution, suspension, ointment, aerosol, sparay, foam, paste, gel. (gel) and patch (patch) characterized in that the anti-therapeutic composition. ※ 참고사항：최초출원 내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.
KR1019970018124A 1996-05-10 1997-05-10 Composition for treatment of freckle KR100200240B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR101996015303 1996-05-10
KR19960015303 1996-05-10
KR96-15303 1996-05-10

Publications (2)

Publication Number Publication Date
KR970073592A true KR970073592A (en) 1997-12-10
KR100200240B1 KR100200240B1 (en) 1999-06-15

Family

ID=19458213

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019970018124A KR100200240B1 (en) 1996-05-10 1997-05-10 Composition for treatment of freckle

Country Status (3)

Country Link
KR (1) KR100200240B1 (en)
AU (1) AU2713797A (en)
WO (1) WO1997042970A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100668492B1 (en) * 2000-04-08 2007-01-12 김대곤 New drug formula for melasma

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8148327B2 (en) * 2007-06-06 2012-04-03 Human Matrix Sciences, Llc Aldosterone induced elastin production
WO2009149441A1 (en) 2008-06-06 2009-12-10 Human Matrix Sciences Llc Aldosterone induced vascular elastin production

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3856934A (en) * 1970-06-24 1974-12-24 A Kligman Skin depigmentation
FR2383663A1 (en) * 1977-03-18 1978-10-13 Nemet Pierre Prepn. of skin cream having de:pigmenting action - contains hydroquinone, retinoic acid and corticoid

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100668492B1 (en) * 2000-04-08 2007-01-12 김대곤 New drug formula for melasma

Also Published As

Publication number Publication date
KR100200240B1 (en) 1999-06-15
AU2713797A (en) 1997-12-05
WO1997042970A1 (en) 1997-11-20

Similar Documents

Publication Publication Date Title
ATE241339T1 (en) FOAMABLE FORMULATION AND FOAM
AU4885196A (en) Corticosteroid-containing pharmaceutical composition
CA2704117C (en) Transdermal delivery system
AU3853395A (en) Preparation of hollow microcapsules
EP2100601A3 (en) Topical pharmaceutical foam composition
DK1112062T3 (en) mousse Composition
ATE235907T1 (en) USE OF COMPETITIVE PROGESTERONE ANTAGONISTS FOR THE PRODUCTION OF MEDICINAL PRODUCTS FOR THE TREATMENT OF DYSFUNCTIONAL UTERINE BLEEDING
EP2292239A3 (en) Remedies for diseases to be applied to eye
KR970073592A (en) Blemish treatment
KR960010008A (en) Aqueous guard suspension
BR9807729A (en) Nimesulide gel systems for topical use
AU2668800A (en) Mixture of plant-treatment agents and waxes, method for producing same and the use thereof
WO1999013819A3 (en) Composition and method for reducing stinging in skin
WO2002046207A3 (en) Process
DE69623641T2 (en) TOPICAL FOAMING MEDICINE FOR THE TREATMENT OF SKIN DISEASES CAUSED BY PITYROSPORUM OVALE
KR910700039A (en) Minoxidil and Vasoconstrictor Compositions for the Treatment of Alopecia
Bhargava et al. The stimulation by the adrenocorticotropic hormone of the phosphorylation of an adrenal mitochondrial preparation
RS20050816A (en) Pure d-(17alpha)-13-ethyl-17-hydroxy- 18,19-dinopregn-4-ene- 20-yne-3-one-3e- and-3z-oxime isomers,as well as process for the synthesis of the mixture of isomers and the pure isomers
KR960037062A (en) Manufacturing method of therapeutic agent for purulent skin disease
JPH05148147A (en) Steroidal external agent
CA2421302A1 (en) 4-halogenated 17-methylene steroids, method for the production thereof and pharmaceutical compositions containing these compounds
DE59907558D1 (en) AGENTS FOR STABILIZING FOOD AND COSMETIC AGENTS AND METHOD FOR THE PRODUCTION THEREOF
DK1161225T3 (en) Dosing aerosol with isobutane as propellant
AU1167097A (en) 18-methyl 16-methylene 19-nor pregnane derivatives as progestins, pharmaceutical compositions containing them and process for the preparation thereof
Miles et al. Use of Limited Proteolysis to Probe Subunit Interaction In the Tryptophan Synthase a₂ß2 Complex

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20130306

Year of fee payment: 15

FPAY Annual fee payment

Payment date: 20140109

Year of fee payment: 16

FPAY Annual fee payment

Payment date: 20160324

Year of fee payment: 18

EXPY Expiration of term